CFP suppresses breast cancer cell growth by TES-mediated upregulation of the transcription factor DDIT3

Area of Science:

• Genetics
• Oncology
• Molecular Biology

Background:

• Breast cancer is a complex genetic disease with numerous mutations.
• Many genes with mutations in primary tumors have unknown roles in cancer progression.
• Identifying novel regulators is crucial for understanding breast cancer and finding new therapeutic targets.

Purpose of the Study:

• To investigate the roles of 86 wild-type genes and 94 mutated variants in breast cancer cell growth.
• To identify novel genes and pathways involved in breast cancer progression.
• To potentially discover new drug targets for breast cancer treatment.

Main Methods:

• Utilized a serially constructed panel of MCF7 cell lines to analyze gene effects on cell growth.
• Conducted experiments to assess the functional impact of specific genes and their variants.
• Employed in vitro and in vivo models to validate findings.

Main Results:

• The metal cation transporter CNNM4 was identified as a regulator of cell growth through the induction of apoptosis.
• Complement factor properdin (CFP) demonstrated a tumor suppressive role.
• CFP was found to upregulate the pro-apoptotic transcription factor DDIT3, linked to endoplasmic reticulum stress.

Conclusions:

• CNNM4 and complement factor properdin (CFP) are significant players in breast cancer development.
• CFP's tumor suppressive function is mediated by the DDIT3-associated endoplasmic reticulum stress response.
• These findings offer insights into breast cancer pathogenesis and potential therapeutic strategies.